Jun Pan

663 total citations
24 papers, 525 citations indexed

About

Jun Pan is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Jun Pan has authored 24 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Rheumatology. Recurrent topics in Jun Pan's work include Natural product bioactivities and synthesis (6 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Fibroblast Growth Factor Research (3 papers). Jun Pan is often cited by papers focused on Natural product bioactivities and synthesis (6 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Fibroblast Growth Factor Research (3 papers). Jun Pan collaborates with scholars based in China, United States and Netherlands. Jun Pan's co-authors include Lin Zeng, Dengying Wu, Hongwei Lü, Weiyang Yu, Rong Chen, Xiucui Li, Chao Jia, Jingdong Zhang, Ningyu Cai and Zhiwei Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Monthly Notices of the Royal Astronomical Society and Cell Death and Disease.

In The Last Decade

Jun Pan

24 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Pan China 13 273 123 120 81 74 24 525
Hsiang‐Ping Lee Taiwan 15 300 1.1× 101 0.8× 149 1.2× 128 1.6× 122 1.6× 16 682
Ju‐Ryoung Kim South Korea 11 306 1.1× 39 0.3× 110 0.9× 63 0.8× 68 0.9× 19 550
Yoshimi Aizaki Japan 11 319 1.2× 63 0.5× 147 1.2× 127 1.6× 90 1.2× 17 725
Xiaojuan Feng China 15 219 0.8× 75 0.6× 72 0.6× 31 0.4× 41 0.6× 27 501
Man Xu China 17 355 1.3× 103 0.8× 24 0.2× 45 0.6× 62 0.8× 29 713
Si Jun Park South Korea 12 203 0.7× 59 0.5× 37 0.3× 29 0.4× 37 0.5× 23 434
Francisco Ruíz-Espejo Spain 14 284 1.0× 35 0.3× 52 0.4× 166 2.0× 34 0.5× 27 639
Ebru Alp Türkiye 16 276 1.0× 169 1.4× 19 0.2× 58 0.7× 95 1.3× 35 626
Weiwei Liu China 11 185 0.7× 45 0.4× 73 0.6× 65 0.8× 82 1.1× 24 476

Countries citing papers authored by Jun Pan

Since Specialization
Citations

This map shows the geographic impact of Jun Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Pan more than expected).

Fields of papers citing papers by Jun Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Pan. The network helps show where Jun Pan may publish in the future.

Co-authorship network of co-authors of Jun Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Pan. A scholar is included among the top collaborators of Jun Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Pan. Jun Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Jianfeng, et al.. (2024). 20- Deoxyingenol attenuate morphine-induced hippocampus neurotoxicity and memory impairments in rats. Heliyon. 10(11). e31605–e31605. 1 indexed citations
2.
Zhong, Xi, Xiaoxue Ke, Xiang Ye, et al.. (2024). Moracin D suppresses cell growth and induces apoptosis via targeting the XIAP/PARP1 axis in pancreatic cancer. Phytomedicine. 128. 155527–155527. 8 indexed citations
3.
Zhao, Gaichao, Chongyang Li, Ruochen Liu, et al.. (2024). OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway. Cell Death and Disease. 15(3). 179–179. 18 indexed citations
4.
Yu, Yanrong, et al.. (2024). Liraglutide ameliorates TAC-induced cardiac hypertrophy and heart failure by upregulating expression level of ANP expression. Heliyon. 10(11). e32229–e32229. 6 indexed citations
5.
Jia, Chao, Xiucui Li, Jun Pan, et al.. (2022). Silencing of Angiopoietin‐Like Protein 4 (Angptl4) Decreases Inflammation, Extracellular Matrix Degradation, and Apoptosis in Osteoarthritis via the Sirtuin 1/NF‐κB Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 1135827–1135827. 13 indexed citations
7.
Lü, Hongwei, Wei Wang, Lin Zeng, et al.. (2021). Hydrogen (H2) Alleviates Osteoarthritis by Inhibiting Apoptosis and Inflammation via the JNK Signaling Pathway. Journal of Inflammation Research. Volume 14. 1387–1402. 19 indexed citations
8.
Lü, Hongwei, Chao Jia, Dengying Wu, et al.. (2021). Fibroblast growth factor 21 (FGF21) alleviates senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the SIRT1-mTOR signaling pathway. Cell Death and Disease. 12(10). 865–865. 85 indexed citations
9.
Pan, Jun, et al.. (2021). Quercetin Increases Doxorubicin-Induced Apoptosis Through Oxidative DNA Damage in KATO III Gastric Cancer Cells. Iranian Red Crescent Medical Journal. 2 indexed citations
10.
Zeng, Lin, et al.. (2020). The protective effect of Ellagic acid (EA) in osteoarthritis: An in vitro and in vivo study. Biomedicine & Pharmacotherapy. 125. 109845–109845. 55 indexed citations
11.
Zeng, Lin, et al.. (2019). Nobiletin Inhibits IL-1β-Induced Inflammation in Chondrocytes via Suppression of NF-κB Signaling and Attenuates Osteoarthritis in Mice. Frontiers in Pharmacology. 10. 570–570. 31 indexed citations
12.
Sun, Liang, Xinyu Li, Jun Pan, et al.. (2019). Seeking mTORC1 Inhibitors Through Molecular Dynamics Simulation of Arginine Analogs Inhibiting CASTOR1. Cancer Genomics & Proteomics. 16(6). 465–479. 4 indexed citations
13.
Wu, Yifan, et al.. (2018). The protective effect of sophocarpine in osteoarthritis: An in vitro and in vivo study. International Immunopharmacology. 67. 145–151. 13 indexed citations
14.
Pan, Jun, et al.. (2018). Circular RNA circNASP modulates the malignant behaviors in osteosarcoma via miR-1253/FOXF1 pathway. Biochemical and Biophysical Research Communications. 500(2). 511–517. 52 indexed citations
15.
Wu, Dengying, et al.. (2017). Alpha-Mangostin protects rat articular chondrocytes against IL-1β-induced inflammation and slows the progression of osteoarthritis in a rat model. International Immunopharmacology. 52. 34–43. 35 indexed citations
17.
Chen, Huan, Rong Chen, Dengying Wu, et al.. (2017). Geniposide Suppresses Interleukin-1β-Induced Inflammation and Apoptosis in Rat Chondrocytes via the PI3K/Akt/NF-κB Signaling Pathway. Inflammation. 41(2). 390–399. 55 indexed citations
18.
Chen, Hui, Kehe Yu, Jingdong Zhang, et al.. (2016). Resveratrol inhibits phosphorylation within the signal transduction and activator of transcription 3 signaling pathway by activating sirtuin 1 in SW1353 chondrosarcoma cells. Molecular Medicine Reports. 14(3). 2685–2690. 9 indexed citations
19.
Ordway, Gregory A., et al.. (2004). Norepinephrine transporter function and desipramine: residual drug effects versus short-term regulation. Journal of Neuroscience Methods. 143(2). 217–225. 12 indexed citations
20.
Pan, Jun, et al.. (1997). Molecular basis of transfer of induced resistance in plants. Tsinghua Science & Technology. 2(1). 463–465. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026